Biovica Competitors and Similar CompaniesClear all

Biovica's competitors and similar companies include Biocept.
Biovica
Biovica
Biovica is a biotech company that develops and commercializes blood-based biomarker assays that help to monitor cancer therapies and predict patient outcomes.
Biocept
Biocept
Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.
Founding Date
Founding Date
2009
Founding Date
1993
Type
Type
Public
Type
Public
Tags
Locations
Locations
Uppsala, SE HQ
Waltham, US
Locations
San Diego, US HQ
Employees
Employees
26
Employees
878% decrease
Valuation ($)
Valuation ($)
20.5 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
kr13.4m (FY, 2026)
Revenue (est.)
$25.9m (FY, 2022)
Cost of goods
Cost of goods
kr43k (FY, 2026)
Cost of goods
$28.4m (FY, 2022)
Gross profit
Gross profit
kr14m (FY, 2026)
Gross profit
($2.5m) (FY, 2022)
Net income
Net income
(kr69.9m) (FY, 2026)
Net income
($32.1m) (FY, 2022)
For sources of this data, please see the company profile

View Company Profiles

Biocept
HQ
San Diego, US
Employees
87↓ 8% decrease

Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer.

View company